The advertisement provides important safety information regarding the risks of serious infections associated with oral Janus kinase inhibitors used for inflammatory conditions.
Creative Information
| CID: | 79293117-bdcb-4e13-809b-838c6a7156f8 |
| CRID: | 89_207538 |
| Domain: | opzelura.com |
| Seat: | DInt |
| Size: | 728x90 |
| Bid: | $5.01 |
| Timestamp: | 11/14/2025, 3:10:02 AM |
| Declared IAB Categories: |
Analysis
5 succeeded(100% complete)
| Task | Status | Last Updated | Duration | Actions |
|---|---|---|---|---|
| ad_analysis | success | 11/25/2025, 9:39:23 PM | 6.27s | |
| adomain_analysis | success | 12/10/2025, 1:45:42 AM | 4.77s | |
| adomain_capture | success | 11/25/2025, 10:13:04 PM | 0.17s | |
| ad_render | success | 11/25/2025, 9:39:16 PM | 31.99s | |
| brand_mapping | success | 11/25/2025, 8:30:52 PM | 0.08s | |
Analysis Results
Ad Format: banner
Brands: Opzelura
Sensitive:Misleading Health ClaimsUnverified Medical TreatmentsPharmaceutical Products
Quality:Adomain not match landing page domain
| Size: | 728x90 | ||||||||||||||||||||||
| Data Transferred: | 3399.58 KB | ||||||||||||||||||||||
| Render Time: | 9.82 Seconds | ||||||||||||||||||||||
| Creative Inferred IAB Categories: |
| ||||||||||||||||||||||
| Creative Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Domain Inferred IAB Categories: |
| ||||||||||||||||||||||
| Domain Inferred IAB Ad Products: |
| ||||||||||||||||||||||
| Landing Page: | |||||||||||||||||||||||
| Total Ad Size: | 3421.12 KB | ||||||||||||||||||||||
| Requests Made: |
|
Advertiser Domain

Ad Preview
Landing Page

Creatives

